ALK inhibitor

May 28, 2019

Roche launches first in vitro diagnostic IHC test to detect ROS1 protein in cancers

May 21, 2019

The anaplastic lymphoma kinase (ALK) inhibitors market will register a CAGR of about 21% by 2023

Jan 24, 2019

Remote Participation Enables Patients with ALK-Positive Lung Cancer from Across the Country to Participate in New Study of Treatment Resistance

Sep 19, 2018

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology

Sep 10, 2018

First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer

Jun 04, 2018

First-Ever Scientific Research Awards Funded by ALK Positive in Partnership with LUNGevity Foundation

May 22, 2018

New Review Highlights the Latest Developments in Pediatric Anaplastic Large Cell Lymphoma

May 01, 2018

Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer

Apr 27, 2018

Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements

Nov 15, 2017

LUNGevity Partners with ALK Positive Patient Group to Fund Lifesaving Research